Literature DB >> 29278858

The Ikaros family in lymphocyte development.

Beate Heizmann1, Philippe Kastner2, Susan Chan3.   

Abstract

The IKZF family of transcription factors are essential regulators of lymphopoiesis. Ikaros, Helios, Aiolos and Eos function as transcriptional repressors and activators during T and B cell differentiation and in mature cell function, depending on the stage of development and/or cell type. Their potential mechanisms of action are varied. Ikaros family proteins partner with multiple complexes, including NuRD, PRC2 and transcription elongation factors, to modulate gene expression and the chromatin state. In humans, mutations in the IKZF genes are associated with B cell deficiency, leukemias and autoimmunity. In this review, we focus on the function of Ikaros family proteins in early T and B lymphocyte development, and discuss the molecular and physiological activities of this family.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29278858     DOI: 10.1016/j.coi.2017.11.005

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  34 in total

1.  Cereblon Based Immunomodulatory Therapeutics.

Authors:  Robert B Kargbo
Journal:  ACS Med Chem Lett       Date:  2020-02-26       Impact factor: 4.345

Review 2.  Helios: still behind the clouds.

Authors:  Angela M Thornton; Ethan M Shevach
Journal:  Immunology       Date:  2019-10-13       Impact factor: 7.397

3.  Transcription factor binding at Ig enhancers is linked to somatic hypermutation targeting.

Authors:  Ravi K Dinesh; Benjamin Barnhill; Anoj Ilanges; Lizhen Wu; Daniel A Michelson; Filip Senigl; Jukka Alinikula; Jeffrey Shabanowitz; Donald F Hunt; David G Schatz
Journal:  Eur J Immunol       Date:  2019-12-19       Impact factor: 5.532

4.  A Point Mutation in IKAROS ZF1 Causes a B Cell Deficiency in Mice.

Authors:  Brigette Boast; Lisa A Miosge; Hye Sun Kuehn; Vicky Cho; Vicki Athanasopoulos; Hayley A McNamara; Yovina Sontani; Yan Mei; Debbie Howard; Henry J Sutton; Sofia A Omari; Zhijia Yu; Mariam Nasreen; T Daniel Andrews; Ian A Cockburn; Christopher C Goodnow; Sergio D Rosenzweig; Anselm Enders
Journal:  J Immunol       Date:  2021-03-03       Impact factor: 5.422

Review 5.  Established and emergent roles for Ikaros transcription factors in lymphoid cell development and function.

Authors:  Kaitlin A Read; Devin M Jones; Aharon G Freud; Kenneth J Oestreich
Journal:  Immunol Rev       Date:  2020-12-17       Impact factor: 12.988

Review 6.  IKAROS-Associated Diseases in 2020: Genotypes, Phenotypes, and Outcomes in Primary Immune Deficiency/Inborn Errors of Immunity.

Authors:  Hye Sun Kuehn; Cristiane J Nunes-Santos; Sergio D Rosenzweig
Journal:  J Clin Immunol       Date:  2021-01-03       Impact factor: 8.317

Review 7.  Germline IKZF1 mutations and their impact on immunity: IKAROS-associated diseases and pathophysiology.

Authors:  Hye Sun Kuehn; Cristiane J Nunes-Santos; Sergio D Rosenzweig
Journal:  Expert Rev Clin Immunol       Date:  2021-03-19       Impact factor: 4.473

8.  Multiple Sclerosis: circRNA Profile Defined Reveals Links to B-Cell Function.

Authors:  Anna E Zurawska; Marcin P Mycko; Igor Selmaj; Cedric S Raine; Krzysztof W Selmaj
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-08-12

9.  Inherited genetic susceptibility to acute lymphoblastic leukemia in Down syndrome.

Authors:  Austin L Brown; Adam J de Smith; Vincent U Gant; Wenjian Yang; Michael E Scheurer; Kyle M Walsh; Jonathan M Chernus; Noah A Kallsen; Shanna A Peyton; Gareth E Davies; Erik A Ehli; Naomi Winick; Nyla A Heerema; Andrew J Carroll; Michael J Borowitz; Brent L Wood; William L Carroll; Elizabeth A Raetz; Eleanor Feingold; Meenakshi Devidas; Lisa F Barcellos; Helen M Hansen; Libby Morimoto; Alice Y Kang; Ivan Smirnov; Jasmine Healy; Caroline Laverdière; Daniel Sinnett; Jeffrey W Taub; Jillian M Birch; Pamela Thompson; Logan G Spector; Maria S Pombo-de-Oliveira; Andrew T DeWan; Charles G Mullighan; Stephen P Hunger; Ching-Hon Pui; Mignon L Loh; Michael E Zwick; Catherine Metayer; Xiaomei Ma; Beth A Mueller; Stephanie L Sherman; Joseph L Wiemels; Mary V Relling; Jun J Yang; Philip J Lupo; Karen R Rabin
Journal:  Blood       Date:  2019-10-10       Impact factor: 25.476

10.  First-in-Human, Single- and Multiple-Ascending-Dose Studies in Healthy Subjects to Assess Pharmacokinetics, Pharmacodynamics, and Safety/Tolerability of Iberdomide, a Novel Cereblon E3 Ligase Modulator.

Authors:  Ying Ye; Allison Gaudy; Peter Schafer; Michael Thomas; Daniel Weiss; Nianhang Chen; Liangang Liu; Yongjun Xue; Leon Carayannopoulos; Maria Palmisano
Journal:  Clin Pharmacol Drug Dev       Date:  2020-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.